Trials

BOSTON, MA: As Part of the Keynote Program for the 2015 Medical Informatics World Conference, May 4-5 in Boston, Dr. Stack Will Present on the Topic of Health IT, Health Reform, and the Path Forward ...

Global Blood Therapeutics Announces First Cohort Dosed in Phase I/II Trial of GBT440 in Sickle Cell Disease

SOUTH SAN FRANCISCO, CA: Company Expects Study to Provide Early Clinical Proof of Concept (POC) for Disease-Modifying Treatment in Second Half of 2015 ...

Cleveland BioLabs and Incuron Announce Updates on Clinical Progress With Curaxin CBL0137

BUFFALO, NY: ...

Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment

MELBOURNE, AUSTRALIA: ...

Cromos Pharma Launches Risk-Sharing Partnerships Program With Biotech and Pharma Companies

PORTLAND, OR: ...

Medifocus, Inc.''s Technology Featured in a Mediaplanet Sponsored Insert in "USA Today" on Breast Cancer

COLUMBIA, MD and TORONTO, ON: John Mon, COO Interviewed as an Expert on the "Future of Cancer Control" ...

Databean Managing Partner, Nuala Ronan, Wins Two Prestigious Awards

WESTCHESTER, NY: Nuala Ronan Honored With a Stevie Award and a 914INC Women in Business Award ...

RepliCel Life Sciences to Present at World Stem Cell Summit 2014

VANCOUVER, BRITISH COLUMBIA: Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and lead an experts' roundtable discussion ...

Proteostasis Therapeutics and Astellas Announce Collaboration for Research, Development and Commercialization of Therapies Modulating the Unfolded Protein Response

CAMBRIDGE, MA. and TOKYO, JAPAN: ...

Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals'' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cance

TUSTIN, CA: Favorable Trends in Both Overall Response Rates of 35% and Median Overall Survival of 12.2 Months Continue to Support Bavituximab's Potential in NSCLC Lead Immuno-Oncology Antibody Bavituximab in ...

Corcept Therapeutics to Announce Third Quarter Financial Results and Host Conference Call

MENLO PARK, CA: ...

Page 4 von 9: 1 2 3 4 5 6 7 8 9

All members:	10 667
Register today:	0
Register yesterday:	0
Members online:	0
Guests online:	269

Trials

Category / Pharmaceuticals & Biotech / Trials

Avita Medical Appoints Adam Kelliher as Chief Executive Officer

Flamel Technologies Announces Departure of Senior Vice President of Business and Corporate Development

Theravance Biopharma to Present at the Needham Healthcare Conference

Medifocus Inc. Announces Equity Offering

SciClone to Present at Investor and Partnering Conferences in China

Horizon Pharma plc Announces That Pre-Clinical Data Show Treatment With Interferon Gamma Improved Signs of Disease Severity of Rare Bone Disease

Cromos(TM) Pharma Launches Cardiorus, a Premier Cardiology and Cardiothoracic Surgery Site Research Organization

Prima BioMed to Receive Financial Milestone Payment From GSK

Prima BioMed Receives $777K R&D Tax Incentive Refund

AMA President-Elect, Dr. Steven Stack, Joins the Medical Informatics World Conference Speaking Faculty